| NCT00112242 | Centre Hospitalier Universitaire Vaudois|Ludwig Institute for Cancer Research | Melanoma | 2004-02 | PHASE1 |
| NCT00185965 | Ronald Levy|Lymphoma Research Foundation|American Society of Clinical Oncology | Non-Hodgkin Lymphoma|Mycosis Fungoides | 2004-07 | PHASE1|PHASE2 |
| NCT01164514 | National Institute of Allergy and Infectious Diseases (NIAID) | Bacterial Sepsis | 2011-11 | PHASE1 |
| NCT04672395 | Clover Biopharmaceuticals AUS Pty|Coalition for Epidemic Preparedness Innovations|International Vaccine Institute | COVID-19 | 2021-03-24 | PHASE2|PHASE3 |
| NCT00043394 | Pfizer | Carcinoma, Breast | 2002-09 | PHASE2 |
| NCT00889616 | National Institute of Allergy and Infectious Diseases (NIAID) | Malaria | 2009-04-23 | PHASE1 |
| NCT00031278 | Pfizer | Carcinoma, Metastatic Breast | 2001-10 | PHASE1|PHASE2 |
| NCT03747393 | Brooke Army Medical Center|University of Utah | Knee Osteoarthritis | 2019-06-01 | NA |
| NCT00984763 | University of Oxford|National Institute of Allergy and Infectious Diseases (NIAID) | Malaria | 2010-01 | PHASE1|PHASE2 |
| NCT03172975 | Baylor College of Medicine|George Washington University|National Institute of Allergy and Infectious Diseases (NIAID) | Hookworm Infections | 2018-03-01 | PHASE2 |
| NCT01351948 | University of Oxford|National Institute of Allergy and Infectious Diseases (NIAID) | Malaria | 2011-06 | PHASE1 |
| NCT00070642 | Pfizer | Carcinoma, Melanoma | 2003-12 | PHASE2 |
| NCT06192602 | Chinese University of Hong Kong|Integrated Community Centers for Mental Wellness | Early Psychosis|Psychotic Disorders | 2023-02-01 | NA |
| NCT04405908 | Clover Biopharmaceuticals AUS Pty | COVID-19 | 2020-06-19 | PHASE1 |
| NCT02143518 | Baylor College of Medicine|George Washington University | Hookworm Infection|Hookworm Disease | 2014-10 | PHASE1 |
| NCT00340574 | National Institute of Allergy and Infectious Diseases (NIAID) | Healthy Volunteer|HV | 2005-03-08 | PHASE1 |
| NCT00562939 | University of Aarhus|Aarhus University Hospital | HIV Infections | 2008-01 | PHASE1|PHASE2 |
| NCT00640861 | Mayo Clinic|National Cancer Institute (NCI) | Breast Cancer | 2008-08-28 | EARLY_PHASE1 |
| NCT00226993 | Stanford University|National Institutes of Health (NIH) | Mycosis Fungoides | 2005-03 | PHASE1|PHASE2 |
| NCT00199836 | Ludwig Institute for Cancer Research | Cancer|Neoplasm | 2003-09-03 | PHASE1 |
| NCT00780988 | Stanford University | Colorectal Neoplasms|Anal, Colon, and Rectal Cancers | | PHASE1 |
| NCT01959880 | Mentor Worldwide, LLC | Breast Augmentation|Breast Reconstruction|Breast Revision | 2013-08 | PHASE3 |
| NCT06334393 | Valneva Austria GmbH | Zika|Zika Virus Infection | 2024-03-25 | PHASE1 |
| NCT00145145 | Ludwig Institute for Cancer Research | Malignant Melanoma | 2005-01-12 | PHASE1|PHASE2 |
| NCT03235167 | Dalian University | Hepatocellular Carcinoma | 2017-10 | PHASE1 |
| NCT00070629 | Pfizer | Carcinoma, Non-Small Cell Lung | 2003-05 | PHASE2 |
| NCT00145158 | Ludwig Institute for Cancer Research | Malignant Melanoma | 2005-01 | PHASE1|PHASE2 |
| NCT03373214 | Baylor College of Medicine|Centre de Recherche Médicale de Lambaréné|George Washington University|Leiden University Medical Center|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|Amsterdam Institute for Global Health and Development | Hookworm Infection|Hookworm Disease | 2018-02-01 | PHASE1 |
| NCT00344539 | National Institute of Allergy and Infectious Diseases (NIAID) | Plasmodium Falciparum Malaria | 2005-05 | PHASE1 |
| NCT00427167 | National Institute of Allergy and Infectious Diseases (NIAID) | Malaria | 2007-01-23 | PHASE1 |
| NCT05012787 | Clover Biopharmaceuticals AUS Pty | COVID-19 | 2021-11-12 | PHASE3 |
| NCT00320658 | National Institute of Allergy and Infectious Diseases (NIAID)|Johns Hopkins Bloomberg School of Public Health | Malaria | 2006-03 | PHASE1 |
| NCT00414336 | National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Allergy and Infectious Diseases@@@Coley Pharmaceutical Group | Malaria | 2006-12-15 | PHASE1 |
| NCT07221162 | National Institute of Allergy and Infectious Diseases (NIAID) | COVID-19 | 2025-12-05 | PHASE1 |
| NCT00740090 | National Institute of Allergy and Infectious Diseases (NIAID) | Malaria|Malaria Infection | 2008-08-11 | PHASE1 |
| NCT03866707 | Wake Forest University Health Sciences | Childhood Cancer | 2019-02-25 | |
| NCT00233506 | University of Iowa|Mayo Clinic|Pfizer|National Cancer Institute (NCI) | Chronic Lymphocytic Leukemia | 2004-07 | PHASE1 |